Comments
Shares of Aurobindo Pharma dropped over 4 per cent in early trade today following media reports that 20 US states have filed a lawsuit against the company alleging price manipulation of two drugs.
On the BSE, the stock opened at Rs 685 and slumped 4.25 per cent to Rs 665.35.
At 1.40 pm, the stock was trading at Rs 688.30, down Rs 6.55 or 0.94 per cent from the previous close.
The scrip opened at Rs 683.85 on the NSE and went down by 4.34 per cent to Rs 664.10. At 1.40 pm, the stock ws trading at Rs 690.50, down Rs 3.75 or 0.54 per cent.
According to news reports, 20 US states have filed a suit in a US district court against six drug manufacturers, including Aurobindo Pharma, for purported price manipulation of doxycycline hyclate, an antibiotic, and glyburide, a drug used for treatment of diabetes.
Meanwhile, BSE has sought clarification from Aurobindo Pharma on the issue, the reply for which is awaited.
The benchmark Sensex was trading at 26,470.88, down 0.18 per cent, from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.